Tag: biopharma

Collaboration to facilitate advanced biologics testing by providing HCP coverage, characterization and quantification assays, and related services to customers globally

The company showcased its comprehensive portfolio of high purity materials, laboratory consumables, bioprocessing solutions, single use technologies, and digital platforms

The new capital will be deployed to scale commercialization of the PathCrisp molecular diagnostics platform, augmenting manufacturing capacity for high-impact tests in human health

The two-day virtual programme brought together more than 20 industry leaders, domain experts, and international regulators

This exclusive agreement is aimed at further accelerating availability of SZC, an innovative and highly effective treatment for Hyperkalaemia to more patients across India

Rimegepant is an orally disintegrating tablet (ODT) - a class of medications called calcitonin gene-related peptide (CGRP) receptor antagonist

The workshops, led by neurologists from KIMS and Yashoda Hospitals along with PRASHO’s public-health team, focus on early recognition, treatment, and workplace adaptation strategies

The Cover Story tracks how between 2015 and 2025, India’s healthcare and biotech firms transformed CSR from basic compliance to strategic, impact-driven initiatives. Also featuring interviews with: Merck Life Science’s Dhananjay Singh on strengthening India’s R&D and lab infrastructure. Maverick Simulation Solutions’ Anuj Chahal on investing Rs 50 crore in R&D, AI, and immersive learning.

The FDA released a new draft guidance proposing major changes to simplify biosimilarity studies and reduce unnecessary clinical testing

India climbs five places in global ranking, driven by growing R&D capacity and generics strength